Showing results (111-120 of 277) with videos related to
Sort By:
Pageof 28
Journal of Cardiovascular Pharmacology|November 25, 2005
Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for the prosurvival kinases PI3K and P42/44MAPKAbigail M Wynne, Mihaela M Mocanu, Derek M YellonCirculation Research|June 28, 2008
Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouseYasuhiro Nishino, Ian G Webb, Sean M Davidson, et al.Heart (British Cardiac Society)|November 26, 2010
Controversies in the cardiovascular management of type 2 diabetesLionel H Opie, Derek M Yellon, Bernard J GershJournal of Molecular and Cellular Cardiology|March 10, 2011
Retrograde heart perfusion: the Langendorff technique of isolated heart perfusionRobert M Bell, Mihaela M Mocanu, Derek M YellonCardiovascular Drugs and Therapy|May 27, 2004
Myocardial protection from either ischaemic preconditioning or nicorandil is not blocked by gliclazideHelen L Maddock, Sylvia M Siedlecka, Derek M YellonCardiovascular Research|February 5, 2003
The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heartRobert M Bell, Helen L Maddock, Derek M YellonPharmacological Research|November 27, 2015
Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanismJaime A Riquelme, Francisco Westermeier, Andrew R Hall, et al.Journal of Molecular and Cellular Cardiology|June 11, 2002
PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioningMihaela M Mocanu, Robert M Bell, Derek M YellonCardiovascular Research|March 24, 2012
Cardioprotection during cardiac surgeryDerek J Hausenloy, Edney Boston-Griffiths, Derek M YellonDisease Models & Mechanisms|January 16, 2010
Cardiac preconditioning for ischaemia: lost in translationAndrew J Ludman, Derek M Yellon, Derek J HausenloyPageof 28